142 related articles for article (PubMed ID: 25604548)
1. High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc.
Stork L; Brück W; Bar-Or A; Metz I
Acta Neuropathol; 2015 Mar; 129(3):467-8. PubMed ID: 25604548
[No Abstract] [Full Text] [Related]
2. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8(+) T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome.
Martin-Blondel G; Bauer J; Uro-Coste E; Biotti D; Averseng-Peaureaux D; Fabre N; Dumas H; Bonneville F; Lassmann H; Marchou B; Liblau RS; Brassat D
Acta Neuropathol; 2015 Mar; 129(3):463-5. PubMed ID: 25589222
[No Abstract] [Full Text] [Related]
3. Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Giacomini PS; Rozenberg A; Metz I; Araujo D; Arbour N; Bar-Or A;
N Engl J Med; 2014 Jan; 370(5):486-8. PubMed ID: 24476450
[No Abstract] [Full Text] [Related]
4. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R
J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.
Shahani L; Shah M; Tavakoli-Tabasi S
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy.
Middel A; Arends JE; van Lelyveld SF; Otto S; Schuurman R; Frijns CJ; Tesselaar K; Hoepelman AI
Neurology; 2015 Jul; 85(1):104-6. PubMed ID: 26041329
[No Abstract] [Full Text] [Related]
7. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
[TBL] [Abstract][Full Text] [Related]
8. Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?
Martin-Blondel G; Cuzin L; Delobel P; Cuvinciuc V; Dumas H; Alvarez M; Massip P; Marchou B
AIDS; 2009 Nov; 23(18):2545-6. PubMed ID: 19907215
[No Abstract] [Full Text] [Related]
9. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Calvi A; De Riz M; Pietroboni AM; Ghezzi L; Maltese V; Arighi A; Fumagalli GG; Jacini F; Donelli C; Comi G; Galimberti D; Scarpini E
Immunotherapy; 2014; 6(1):23-8. PubMed ID: 24341880
[TBL] [Abstract][Full Text] [Related]
10. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Métivier D; Arnaud FX; Dutasta F; Nguema B; Teriitehau C; Berets O; Baccialone J; Potet J
Diagn Interv Imaging; 2013 Jan; 94(1):101-3. PubMed ID: 23228283
[No Abstract] [Full Text] [Related]
12. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
Bernard-Valnet R; Moisset X; Maubeuge N; Lefebvre M; Ouallet JC; Roumier M; Lebrun-Frenay C; Ciron J; Biotti D; Clavelou P; Godeau B; Du Pasquier RA; Martin-Blondel G
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728496
[TBL] [Abstract][Full Text] [Related]
13. Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS.
Lauda F; Fangerau T; Javaheripour-Otto K; Pinkhardt E; Kassubek J; Tumani H
J Neurol; 2015; 262(4):1055-7. PubMed ID: 25663412
[No Abstract] [Full Text] [Related]
14. CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
Martin-Blondel G; Brassat D; Bauer J; Lassmann H; Liblau RS
Nat Rev Neurol; 2016 Feb; 12(2):95-105. PubMed ID: 26782333
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of immune reconstitution inflammatory syndrome and progressive multifocal leukoencephalopathy after natalizumab withdrawal].
Yakushina TI; Yakushin DM; Shtang IO
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):116-121. PubMed ID: 36946407
[TBL] [Abstract][Full Text] [Related]
16. Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?
Januel E; Martin-Blondel G; Lamirel C; Picard H; Pialoux G; Katlama C; Cochereau I; Lescure FX; Moulignier A
J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1125-1126. PubMed ID: 29305436
[No Abstract] [Full Text] [Related]
17. Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.
del Pilar Martin M; Cravens PD; Winger R; Frohman EM; Racke MK; Eagar TN; Zamvil SS; Weber MS; Hemmer B; Karandikar NJ; Kleinschmidt-DeMasters BK; Stüve O
Arch Neurol; 2008 Dec; 65(12):1596-603. PubMed ID: 18852339
[TBL] [Abstract][Full Text] [Related]
18. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
[TBL] [Abstract][Full Text] [Related]
19. [Progressive multifocal leukoencephalopathy and natalizumab-related immune reconstitution inflammatory syndrome: the advantage of MRI].
Gibelin N; Daelman L; Goulipian S; Wynckel A; Chaunu MP; Tourbah A
Rev Neurol (Paris); 2014 Jan; 170(1):48-50. PubMed ID: 24139244
[No Abstract] [Full Text] [Related]
20. Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia.
Harel A; Horng S; Gustafson T; Ramineni A; Farber RS; Fabian M
J Neurovirol; 2018 Oct; 24(5):652-655. PubMed ID: 29987583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
